Gavin J Churchyard

13PUBLICATIONS
85CO-AUTHORS
Foetal development and medicineEpidemiological methodsInnate immunityEpidemiological modellingMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 16, 2026
Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.

|Mar 17, 2026
Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countries.

Belén Saavedra-Cervera, Dinis Nguenha, Violet Chihota

|Mar 05, 2026
Imprecision in tuberculosis infection outcomes: implications for non-inferiority vaccine trials.

Daniel J Grint, Richard G White, Gavin Churchyard

|Feb 18, 2026
Risk factors for immunological sensitization to Mycobacterium tuberculosis and progression to incident TB disease among HIV-uninfected adults in a high burden setting.

Humphrey Mulenga, Simon C Mendelsohn, Andrew Fiore-Gartland

|Feb 12, 2026
Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study.

Hira Tanvir, Rebecca A Clark, Tom Sumner

|Feb 09, 2026
Optimized Mass Spectrometry to Uncover M. tuberculosis Biomarkers in Extracellular Vesicles from Asymptomatic Tuberculosis Patients.

Luisa Maria Nieto Ramirez, Kimberly Shelton, John T Belisle

Pageof 3

Frequent Collaborators

3 joint publications

Richard G White

2 joint publications

Kogieleum Naidoo

2 joint publications

Humphrey Mulenga

2 joint publications

Thomas Scriba